Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | GAA | P10253 | 1/20 | 0.55 |
| ▸ | RAB9A | P51151 | 2/20 | 0.54 |
| ▸ | IDO1 | P14902 | 2/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | HTR2A | P28223 | 1/20 | 0.53 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.53 |
| ▸ | MAOB | P27338 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9518912 | 0.88 | ALDH1A1 (0.55) | ALDH1A1MAPTGAARAB9AIDO1 | |
| SCHEMBL28374567 | 0.87 | BCL9 (0.63) | ALDH1A1MAPTGAARAB9AIDO1 | |
| SCHEMBL1555636 | 0.86 | ALDH1A1 (0.59) | ALDH1A1MAPTGAARAB9AIDO1 | |
| SCHEMBL9344653 | 0.86 | LMNA (0.57) | ALDH1A1MAPTGAARAB9AIDO1 | |
| SCHEMBL7899725 | 0.85 | ALDH1A1 (0.53) | ALDH1A1MAPTGAARAB9AIDO1 | |
| SCHEMBL7729899 | 0.85 | ALDH1A1 (0.58) | ALDH1A1MAPTGAARAB9AIDO1 | |
| SCHEMBL5235557 | 0.85 | IDO1 (0.56) | ALDH1A1MAPTGAARAB9AIDO1 | |
| SCHEMBL13296291 | 0.85 | ALDH1A1 (0.42) | ALDH1A1MAPTGAARAB9AL3MBTL1 | |
| SCHEMBL29288517 | 0.84 | RAB9A (0.56) | ALDH1A1MAPTGAARAB9AIDO1 | |
| SCHEMBL10592367 | 0.84 | ALDH1A1 (0.49) | ALDH1A1MAPTGAARAB9AIDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200360317-A1 | CARBOXYLIC ACIDS FOR TREATING/PREVENTING A SKIN DISEASE | PROPONENT BIOTECH GMBH (CH) | 2020-11-19 | — | — | US | claimed |
| US-20190160030-A1 | CARBOXYLIC ACIDS FOR EARLY CHILDHOOD APPLICATION | PROPONENT BIOTECH GMBH (CH) | 2019-05-30 | — | — | US | claimed |
| US-20160250168-A1 | ESTERS OF SHORT CHAINS FATTY ACIDS FOR USE IN THE TREATMENT OF IMMUNOGENIC DISORDERS | PROPONENT BIOTECH GMBH (CH) | 2016-09-01 | — | — | US | claimed |
| US-20150246015-A1 | Esters of Short Chains Fatty Acids for Use in the Treatment of Immunogenic Disorders | PROPONENT BIOTECH GMBH (CH) | 2015-09-03 | — | — | US | claimed |
| EP-2903608-A1 | ESTERS OF SHORT CHAINS FATTY ACIDS FOR USE IN THE TREATMENT OF IMMUNOGENIC DISORDERS | Proponent Biotech GmbH (CH) | 2015-08-12 | — | — | EP | claimed |
| WO-2014053592-A1 | ESTERS OF SHORT CHAINS FATTY ACIDS FOR USE IN THE TREATMENT OF IMMUNOGENIC DISORDERS | PROPONENT BIOTECH GMBH (CH) | 2014-04-10 | — | — | WO | claimed |
| WO-2012131069-A1 | SHORT CHAIN FATTY ACIDS AND THEIR DERIVATIVES FOR USE IN TREATMENT IMMUNOGENIC DISORDERS | PROPONENT BIOTECH GMBH (CH) | 2012-10-04 | — | — | WO | claimed |
| US-20200360317-A1 | CARBOXYLIC ACIDS FOR TREATING/PREVENTING A SKIN DISEASE | PROPONENT BIOTECH GMBH (CH) | 2020-11-19 | — | — | US | disclosed |
| EP-2903608-B1 | PHARMACEUTICAL COMPOSITION COMPRISING PROPIONIC ACID FOR USE IN THE TREATMENT OF VIRAL INFECTIONS | PROPONENT BIOTECH GMBH (CH) | 2019-08-28 | — | — | EP | disclosed |
| US-20190160030-A1 | CARBOXYLIC ACIDS FOR EARLY CHILDHOOD APPLICATION | PROPONENT BIOTECH GMBH (CH) | 2019-05-30 | — | — | US | disclosed |
| US-9884032-B2 | Esters of short chains fatty acids for use in the treatment of immunogenic disorders | PROPONENT BIOTECH GMBH (CH) | 2018-02-06 | — | — | US | disclosed |
| US-20160250168-A1 | ESTERS OF SHORT CHAINS FATTY ACIDS FOR USE IN THE TREATMENT OF IMMUNOGENIC DISORDERS | PROPONENT BIOTECH GMBH (CH) | 2016-09-01 | — | — | US | disclosed |
| US-9415033-B2 | Esters of short chains fatty acids for use in the treatment of immunogenic disorders | PROPONENT BIOTECH GMBH (CH) | 2016-08-16 | — | — | US | disclosed |
| WO-2012131069-A1 | SHORT CHAIN FATTY ACIDS AND THEIR DERIVATIVES FOR USE IN TREATMENT IMMUNOGENIC DISORDERS | PROPONENT BIOTECH GMBH (CH) | 2012-10-04 | — | — | WO | disclosed |
| US-20120190880-A1 | METHODS AND COMPOSITIONS FOR PREPARATION OF AMPHETAMINE CONJUGATES AND SALTS THEREOF | BLUE OWL CAPITAL CORPORATION, AS NEW AGENT | 2012-07-26 | — | — | US | disclosed |
| US-20120157706-A1 | Methods and Compositions for Preparing Lisdexamfetamine and Salts Thereof | AVISTA PHARMA SOLUTIONS, INC. | 2012-06-21 | — | — | US | disclosed |
| CN-101967096-A | 3-[4-(alkoxy) phenyl] propionate compound and preparation method and application thereof | UNIV SICHUAN | 2011-02-09 | — | — | CN | disclosed |
| US-7407952-B2 | Reverse-turn mimetics and compositions and methods related thereto | MYRIAD GENETICS, INC. (US) | 2008-08-05 | — | — | US | disclosed |
| EP-1517881-A1 | 4-(3,3-DIHALO-ALLYLOXY)PHENOXY ALKYL DERIVATIVES | Syngenta Participations AG (CH) | 2005-03-30 | — | — | EP | disclosed |
| WO-2004002943-A1 | 4-(3,3-DIHALO-ALLYLOXY)PHENOXY ALKYL DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2004-01-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120190880-A1 | METHODS AND COMPOSITIONS FOR PREPARATION OF AMPHETAMINE CONJUGATES AND SALTS THEREOF | PNMT, COMT, DDT | ALDH1A1 616/4885MAPT 350/4885GAA 415/4885 |
| US-20160250168-A1 | ESTERS OF SHORT CHAINS FATTY ACIDS FOR USE IN THE TREATMENT OF IMMUNOGENIC DISORDERS | TSLP, HLA-DRB1, LTA | ALDH1A1 1571/4885MAPT 1948/4885GAA 638/4885 |
| US-20120157706-A1 | Methods and Compositions for Preparing Lisdexamfetamine and Salts Thereof | SLC6A3, COMT, LPXN | ALDH1A1 1883/4885MAPT 60/4885GAA 25/4885 |
| US-20150246015-A1 | Esters of Short Chains Fatty Acids for Use in the Treatment of Immunogenic Disorders | TSLP, HLA-DRB1, LTA | ALDH1A1 1571/4885MAPT 1948/4885GAA 638/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.